Latest profit margin for Abivax: -7615.97% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
As of the most recent data (December 2025), ABVX shows a profit margin of -7615.97%. That is below the Healthcare sector average of 13.89%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average profit margin is about 13.89%. Abivax is at -7615.97%, which is lower that average. That is roughly 54918.5% below the sector mean. Use the comparison chart on this page to see how ABVX stacks up against individual peers as well.
Check the historical chart to see whether ABVX's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Abivax with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Abivax's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -7615.97%) with ownership activity and broader fundamentals.
The Healthcare average profit margin is about 13.89%, while ABVX is at -7615.97%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.